GLP-1 is the hottest NEW weight loss treatment and was brought to market by Eli Lilly and Company (NYSE:LLY) in January of this year, propelling its stock to rise 35% this year.
The company we are talking about has over $100 million in trailing 12 month revenues, and the CEO is insinuating that its upcoming new weight loss GLP-1 product launch “will be a “game changer.”